Skip to main content
Top
Published in: Diabetologia 9/2010

01-09-2010 | Short Communication

Proteinuria modifies the effects of physical activity on total and cardiovascular disease mortality rates in patients with type 2 diabetes

Authors: T. Vepsäläinen, M. Soinio, S. Lehto, A. Juutilainen, M. Laakso, T. Rönnemaa

Published in: Diabetologia | Issue 9/2010

Login to get access

Abstract

Aims/hypothesis

Physical activity reduces cardiovascular disease (CVD) and total mortality rates in patients with type 2 diabetes. However, it is not known whether or not the effects of physical activity on mortality rates depend on the presence of proteinuria in type 2 diabetic patients.

Methods

We prospectively followed up 577 patients with type 2 diabetes who were aged 45 to 64 years and were free of CVD at baseline. Participants were stratified according to the presence of proteinuria (≤300 or >300 mg/l) and the degree of physical activity (0–4 metabolic equivalent tasks [MET] or >4 MET). The Cox proportional hazards model was used to estimate the association of physical activity and proteinuria with risk of mortality.

Results

During the 18-year follow-up, 356 patients died, of whom 217 died from CVD. Physically more active patients had significantly reduced total, CVD and CHD mortality rates if they did not have proteinuria. In contrast, physically active proteinuric patients had significantly increased total and CVD mortality rates (HR 1.83, 95% CI 1.00–3.36, p=0.049) in univariate analyses, with HR 2.43 (95% CI 1.09–5.40, p=0.030) in multivariate analyses.

Conclusions/interpretation

Physical activity reduces total and CVD mortality rates in type 2 diabetic patients without proteinuria. However, in proteinuric patients, no protective effect was observed. Larger studies are needed to confirm the latter finding and to define which exercise intensity leads to possible harmful effects.
Literature
1.
go back to reference Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I (1988) Atherosclerotic vascular disease and its risk factors in non-insulin dependent diabetic and non-diabetic subjects in Finland. Diabetes Care 11:449–463CrossRefPubMed Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I (1988) Atherosclerotic vascular disease and its risk factors in non-insulin dependent diabetic and non-diabetic subjects in Finland. Diabetes Care 11:449–463CrossRefPubMed
2.
go back to reference Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA (1995) Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA 273:1093–1098CrossRefPubMed Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA (1995) Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA 273:1093–1098CrossRefPubMed
3.
go back to reference Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1996) Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27:2033–2039PubMed Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1996) Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 27:2033–2039PubMed
4.
go back to reference Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219–226CrossRefPubMed Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32:219–226CrossRefPubMed
5.
go back to reference Hu G, Eriksson J, Barengo NC et al (2004) Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. Circulation 110:666–673CrossRefPubMed Hu G, Eriksson J, Barengo NC et al (2004) Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. Circulation 110:666–673CrossRefPubMed
6.
go back to reference Marwick TH, Hordern MD, Miller T et al (2009) Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119:3244–3262CrossRefPubMed Marwick TH, Hordern MD, Miller T et al (2009) Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119:3244–3262CrossRefPubMed
8.
go back to reference Mälkiä E, Impivaara O, Maatela J, Aromaa A, Heliövaara M, Knekt P (1988) Physical activity of Finnish adults. Series ML 80. Social Insurance Institution, Turku Mälkiä E, Impivaara O, Maatela J, Aromaa A, Heliövaara M, Knekt P (1988) Physical activity of Finnish adults. Series ML 80. Social Insurance Institution, Turku
9.
go back to reference Kojda G, Hambrecht R (2005) Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67:187–197CrossRefPubMed Kojda G, Hambrecht R (2005) Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67:187–197CrossRefPubMed
10.
go back to reference Čolak E, Majkić-Singh N, Stanković S et al (2005) Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med 37:613–620CrossRefPubMed Čolak E, Majkić-Singh N, Stanković S et al (2005) Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med 37:613–620CrossRefPubMed
Metadata
Title
Proteinuria modifies the effects of physical activity on total and cardiovascular disease mortality rates in patients with type 2 diabetes
Authors
T. Vepsäläinen
M. Soinio
S. Lehto
A. Juutilainen
M. Laakso
T. Rönnemaa
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1812-y

Other articles of this Issue 9/2010

Diabetologia 9/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.